Tracy L. Matlock
Lawyers
Filters
Davis Polk Advises Valeant Pharmaceuticals International, Inc. on Its $2.05 Billion Refinancing
Davis Polk advised Valeant Pharmaceuticals International, Inc. in connection with a refinancing transaction pursuant to which its indirect wholly owned subsidiary, Valeant Pharmaceuticals…
Davis Polk Advises Ankura on Its Acquisition of c3/consulting
Davis Polk is advising Ankura Consulting Group, LLC on its acquisition of C3 Consulting, LLC. The transaction is expected to close by the end of the month, subject to customary closing…
Davis Polk Advises Valeant Pharmaceuticals International, Inc. on Its $1.5 Billion Refinancing
Davis Polk advised Valeant Pharmaceuticals International, Inc. (“Valeant”) in connection with a refinancing transaction pursuant to which its indirect wholly owned subsidiary, Valeant…
Warner Music Group Corp. Refinancing
Davis Polk advised the joint book-running managers and the initial purchasers in a Rule 144A/Regulation S offering of $325 million principal amount of senior notes due 2026 of WMG…
Ingersoll-Rand Global Holding Company Limited $1.15 Billion Senior Notes Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering of senior notes by Ingersoll-Rand Global…
Intel Corporation Exchange and Tender Offers
Davis Polk advised the dealer managers in connection with the offers by Intel Corporation to exchange any and all of its outstanding $1.5 billion 4.80% senior notes due 2041, $925…
Genpact Limited $303 Million Block Trade
Davis Polk advised the sole underwriter in connection with a block trade of 10,000,000 common shares of Genpact Limited by funds affiliated with Bain Capital Investors, LLC and its co…
Davis Polk Advises McKesson Corporation on Its Acquisition of RxCrossroads from CVS Health Corporation
Davis Polk is advising McKesson Corporation on its acquisition of RxCrossroads, a provider of tailored services to pharmaceutical and biotechnology manufacturers, from CVS Health…
Davis Polk Advises PPL Capital Funding, Inc. on Its $500 Million Senior Notes Offering
Davis Polk advised PPL Capital Funding, Inc. on its registered offering of $500 million aggregate principal amount of 4.000% senior notes due 2047, fully and unconditionally guaranteed by…
Genpact Limited Block Trade
Davis Polk advised the underwriter in connection with a block trade of 10,000,000 common shares of Genpact Limited by funds affiliated with Bain Capital Investors, LLC and its co…